Literature DB >> 7908077

Hepatocyte proliferation as an indicator of outcome in acute alcoholic hepatitis.

J W Fang1, G L Bird, T Nakamura, G L Davis, J Y Lau.   

Abstract

To determine whether clinical outcome in patients with acute alcoholic hepatitis is related to the regenerative capability of the liver, liver biopsy specimens from 25 prospectively recruited patients with acute alcoholic hepatitis were studied for hepatic expression of mRNA for two proliferation markers, proliferating cell nuclear antigen and human histone, and for transforming growth factor alpha (TGF alpha) and TGF beta 1 and hepatocyte growth factor (HGF), which regulate hepatocyte proliferation. Proliferation markers were detected to varying degrees in 0-80% of hepatocytes and occasionally in sinusoidal cells and bile-duct epithelium in 19 patients (76%). Patients who survived for 6 months had greater expression of proliferation markers than those who did not survive (p < 0.01). TGF alpha was detected in hepatocytes and bile-duct epithelium, whereas TGF beta 1 was detected mainly in sinusoidal cells and was associated with perivenular fibrosis. Patients who survived for 6 months had greater expression of TGFs than non-survivors (p < 0.02). HGF was detected in sinusoidal cells in 7 patients and correlated with survival (p < 0.01). These data indicate that hepatocyte proliferation, which is possibly related to the pattern of hepatotrophic factor expression, is a good indicator of outcome in acute alcoholic hepatitis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7908077     DOI: 10.1016/s0140-6736(94)92025-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  14 in total

1.  Alcoholic liver disease - Hepatocellular carcinoma transformation.

Authors:  Samuel W French; James Lee; Jim Zhong; Timothy R Morgan; Virgil Buslon; William Lungo; Barbara A French
Journal:  J Gastrointest Oncol       Date:  2012-09

2.  Expression of transforming growth factor-alpha and -beta in hepatic lobes after hemihepatic portal vein embolization.

Authors:  Koji Kusaka; Hiroshi Imamura; Tomoaki Tomiya; Tadatoshi Takayama; Masatoshi Makuuchi
Journal:  Dig Dis Sci       Date:  2006-07-13       Impact factor: 3.199

3.  Mallory-Denk bodies form when EZH2/H3K27me3 fails to methylate DNA in the nuclei of human and mice liver cells.

Authors:  B A French; J Oliva; F Bardag-Gorce; J Li; J Zhong; V Buslon; S W French
Journal:  Exp Mol Pathol       Date:  2012-03-21       Impact factor: 3.362

4.  Hepatic expression of hepatocyte growth factor gene mRNA in acute liver failure.

Authors:  P Harrison; C Gove; A Bomford
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

5.  Modulation of fatty acid and bile acid metabolism by peroxisome proliferator-activated receptor α protects against alcoholic liver disease.

Authors:  Heng-Hong Li; John B Tyburski; Yi-Wen Wang; Steve Strawn; Bo-Hyun Moon; Bhaskar V S Kallakury; Frank J Gonzalez; Albert J Fornace
Journal:  Alcohol Clin Exp Res       Date:  2014-04-28       Impact factor: 3.455

6.  Alcohol consumption promotes diethylnitrosamine-induced hepatocarcinogenesis in male mice through activation of the Wnt/β-catenin signaling pathway.

Authors:  Kelly E Mercer; Leah Hennings; Neha Sharma; Keith Lai; Mario A Cleves; Rebecca A Wynne; Thomas M Badger; Martin J J Ronis
Journal:  Cancer Prev Res (Phila)       Date:  2014-04-28

7.  Zinc supplementation enhances hepatic regeneration by preserving hepatocyte nuclear factor-4alpha in mice subjected to long-term ethanol administration.

Authors:  Xinqin Kang; Zhenyuan Song; Craig J McClain; Y James Kang; Zhanxiang Zhou
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

8.  Hepatocyte growth factor leads to recovery from alcohol-induced fatty liver in rats.

Authors:  M Tahara; K Matsumoto; T Nukiwa; T Nakamura
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

9.  ACG Clinical Guideline: Alcoholic Liver Disease.

Authors:  Ashwani K Singal; Ramon Bataller; Joseph Ahn; Patrick S Kamath; Vijay H Shah
Journal:  Am J Gastroenterol       Date:  2018-01-16       Impact factor: 10.864

Review 10.  Molecular targets in the treatment of alcoholic hepatitis.

Authors:  Ashwin D Dhanda; Richard Wl Lee; Peter L Collins; C Anne McCune
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.